ASSOCIATED RETINAL CONSULTANTS, PC
NPI: 1215003793
· ROYAL OAK, MI 48073
· 207W00000X
$21.12M
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
| 2018 |
20,352 |
$2.67M |
| 2019 |
20,182 |
$2.62M |
| 2020 |
16,296 |
$2.50M |
| 2021 |
20,534 |
$3.17M |
| 2022 |
21,684 |
$3.27M |
| 2023 |
24,512 |
$3.71M |
| 2024 |
20,562 |
$3.18M |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Aflibercept injection |
10,548 |
10,210 |
$11.70M |
| J2778 |
Ranibizumab injection |
7,523 |
7,250 |
$4.86M |
| 99214 |
|
22,653 |
21,874 |
$1.11M |
| 67028 |
|
24,990 |
23,691 |
$799K |
| J2777 |
Inj, faricimab-svoa, 0.1mg |
447 |
431 |
$468K |
| 92134 |
|
31,895 |
31,133 |
$451K |
| 92235 |
|
4,153 |
4,113 |
$218K |
| J9035 |
Bevacizumab injection |
4,251 |
3,942 |
$214K |
| 92014 |
|
8,267 |
8,118 |
$213K |
| 99204 |
|
2,439 |
2,433 |
$207K |
| 92250 |
|
8,750 |
8,499 |
$167K |
| 99215 |
Prolong outpt/office vis |
1,719 |
1,442 |
$163K |
| 99205 |
Prolong outpt/office vis |
822 |
821 |
$93K |
| 92004 |
|
1,355 |
1,338 |
$90K |
| 99213 |
|
2,056 |
2,028 |
$70K |
| J7312 |
Dexamethasone intra implant |
79 |
65 |
$56K |
| 92226 |
|
4,298 |
2,780 |
$55K |
| 67228 |
|
330 |
294 |
$54K |
| 92201 |
|
3,604 |
3,200 |
$47K |
| 76512 |
|
951 |
819 |
$26K |
| 67113 |
|
51 |
30 |
$24K |
| 92225 |
|
1,250 |
834 |
$18K |
| J3590 |
Unclassified biologics |
125 |
105 |
$6K |
| 92202 |
|
826 |
816 |
$6K |
| 92227 |
|
580 |
259 |
$5K |
| 92012 |
|
123 |
121 |
$2K |
| J7999 |
Compounded drug, noc |
16 |
14 |
$1K |
| 99212 |
|
21 |
21 |
$257.99 |